NCT00754689View on ClinicalTrials.gov

Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rimonabant

Tablet, oral administration

DRUG

Metformin

Tablet, oral administration

DRUG

placebo

Tablet, oral administration

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY